找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biopharmaceutics Applications in Drug Development; Rajesh Krishna,Lawrence Yu Book 2008 Springer-Verlag US 2008 absorption.bioequivalence.

[復(fù)制鏈接]
樓主: Colossal
21#
發(fā)表于 2025-3-25 06:11:30 | 只看該作者
22#
發(fā)表于 2025-3-25 10:45:55 | 只看該作者
978-1-4419-4434-4Springer-Verlag US 2008
23#
發(fā)表于 2025-3-25 14:56:29 | 只看該作者
Rajesh Krishna,Lawrence Yudiscusses state of the art knowledge in biopharmaceutics.identifies key issues and opportunities in a distinct problem-solving approach
24#
發(fā)表于 2025-3-25 18:40:44 | 只看該作者
http://image.papertrans.cn/b/image/188319.jpg
25#
發(fā)表于 2025-3-25 22:38:29 | 只看該作者
Molecular and Physicochemical Properties Impacting OralAbsorptionofDrugs,ase of compliance, and cost-effectiveness. Not surprisingly, desirable oral bioavailability is one of the most important considerations for the successful development of bioactive molecules. Poor oral bioavailability affects drug performance and leads to high intra- and inter-patient variability.
26#
發(fā)表于 2025-3-26 04:01:22 | 只看該作者
performance is a vital aspect of new drug development as it draws on interdisciplinary expertise from both pharmaceutics and pharmacokinetics disciplines. It is at the key interface that the discipline of biopharmaceutics has emerged. The past two decades have witnessed considerable advances in bio
27#
發(fā)表于 2025-3-26 08:02:47 | 只看該作者
H. J. K?lsch,P. Rairoux,J. P. Wolf,L. W?stefulfill the same safety profile as a drug with the exception that it should not exert a therapeutic effect. Most excipients do comply with these requirements and do have the GRAS (generally regarded as safe, a system used by the US FDA) status when used in those amounts which are normally used to fabricate a drug delivery system.
28#
發(fā)表于 2025-3-26 10:19:27 | 只看該作者
29#
發(fā)表于 2025-3-26 15:31:25 | 只看該作者
Excipients as Absorption Enhancers,fulfill the same safety profile as a drug with the exception that it should not exert a therapeutic effect. Most excipients do comply with these requirements and do have the GRAS (generally regarded as safe, a system used by the US FDA) status when used in those amounts which are normally used to fabricate a drug delivery system.
30#
發(fā)表于 2025-3-26 19:17:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 19:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
和硕县| 松溪县| 缙云县| 河间市| 曲松县| 营山县| 宁德市| 大方县| 三门县| 全州县| 司法| 永丰县| 舒城县| 百色市| 阿拉善左旗| 峨边| 曲麻莱县| 吐鲁番市| 衡东县| 陕西省| 陆河县| 绥德县| 海南省| 沅陵县| 监利县| 巴彦县| 大庆市| 广饶县| 大港区| 嵩明县| 会理县| 云梦县| 寿阳县| 德钦县| 江西省| 麻城市| 巫山县| 北川| 上蔡县| 图们市| 保靖县|